Shantha Biologics

Shantha Biologics, a vaccine and biopharmaceutical manufacturer in Hyderabad, India, signed a cartridge filling contract with Novo Nordisk in 2024/2025 to fill pre-filled cartridges with sterile pharmaceutical preparations and assemble them into injection pens for self-injection therapies such as insulin, GLP-1, antibodies, etc. Its automated bottle filling line has been approved by the FDA in the United States, publicly disclosing an annual capacity of about 130 million bottles for supply to the Novo Nordisk global supply chain, and plans to expand the manufacture of vaccines, biopharmaceuticals and sterile injectables. This capacity is a single cavity cassette bottle (insulin/GLP-1 pen type) filling, and the dual cavity cassette bottle is not specified in the public information.